Becton, Dickinson and Company

NYSE:BDXB Stock Report

Market Cap: US$70.5b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Becton Dickinson Past Earnings Performance

Past criteria checks 4/6

Becton Dickinson has been growing earnings at an average annual rate of 24.7%, while the Medical Equipment industry saw earnings growing at 9.9% annually. Revenues have been growing at an average rate of 4.7% per year. Becton Dickinson's return on equity is 6.4%, and it has net margins of 8.3%.

Key information

24.71%

Earnings growth rate

23.04%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate4.72%
Return on equity6.41%
Net Margin8.27%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Becton Dickinson makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:BDXB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2318,8091,5564,7911,266
31 Dec 2218,7381,4864,7511,255
30 Sep 2218,8701,5454,7261,256
30 Jun 2218,9581,4134,7741,324
31 Mar 2218,9241,4304,8451,339
31 Dec 2118,5341,0794,7501,302
30 Sep 2119,1311,5144,7201,279
30 Jun 2119,0661,4864,6321,210
31 Mar 2118,3131,3794,4091,142
31 Dec 2018,2071,5074,3461,117
30 Sep 2016,0742454,1781,039
30 Jun 2016,9177864,2161,067
31 Mar 2017,4149234,3131,057
31 Dec 1917,3557604,3791,044
30 Sep 1917,2901,0814,3341,032
30 Jun 1917,1087844,3451,039
31 Mar 1917,0369264,3531,063
31 Dec 1817,0638944,3251,071
30 Sep 1815,9831594,0291,004
30 Jun 1814,7476213,689947
31 Mar 1813,503-993,325857
31 Dec 1712,2512942,991783
30 Sep 1712,0931,0302,953770
30 Jun 1712,1587592,947807
31 Mar 1712,3211,3142,957827
31 Dec 1612,4191,3092,966823
30 Sep 1612,4839763,005828
30 Jun 1612,3121,1392,966771
31 Mar 1612,2348102,988743
31 Dec 1511,2176882,767690
30 Sep 1510,2826952,563632
30 Jun 159,4108152,350570
31 Mar 158,4481,0792,127529
31 Dec 148,4681,1502,141527
30 Sep 148,4461,1852,145524
30 Jun 148,3459742,117522
31 Mar 148,2399412,102506
31 Dec 138,1699302,091502
30 Sep 138,0549292,059494
30 Jun 137,9201,1142,004490
31 Mar 137,8481,1321,960484
31 Dec 127,7761,1311,934478
30 Sep 127,7081,1101,920472
30 Jun 127,7291,1201,913468

Quality Earnings: BDXB has high quality earnings.

Growing Profit Margin: BDXB's current net profit margins (8.3%) are higher than last year (7.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BDXB has become profitable over the past 5 years, growing earnings by 24.7% per year.

Accelerating Growth: BDXB's earnings growth over the past year (8.8%) is below its 5-year average (24.7% per year).

Earnings vs Industry: BDXB earnings growth over the past year (8.8%) exceeded the Medical Equipment industry 1.2%.

Return on Equity

High ROE: BDXB's Return on Equity (6.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/02 06:26
End of Day Share Price 2023/05/31 00:00
Earnings2023/03/31
Annual Earnings2022/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Becton, Dickinson and Company is covered by 42 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Adam FeinsteinBarclays